BioCompoundingExploring Drug Modalities: Small Molecules, Biologics, RNA, Cell & Gene TherapyMultiple different drug modalities are used as therapeutics for the treatment of different diseases or illnesses. In this post, we will…Jan 15, 2023Jan 15, 2023
BioCompoundingCan Precision Fermentation together with Synthetic Biology Help to Secure Our Food Systems?The recent geopolitical tensions and climate change have brought our food system under strain forcing governments to limit exports to…Dec 11, 2022Dec 11, 2022
BioCompoundingWhat is DNA, RNA and Protein and how they are connected by the Central Dogma?In this post, we are going to look at and understand the importance of Central Dogma which interlinks DNA, RNA and Protein and how each is…Dec 7, 2022Dec 7, 2022
BioCompoundingWhat are some investing lessons you learnt in 2022?I share 4 lessons I learnt from the downturnNov 27, 2022Nov 27, 2022
BioCompounding5 Blockbuster Drugs Which Can Be Spun Out as a CompanyNot all drugs are equal.Nov 21, 2022Nov 21, 2022
BioCompoundingAre RSV vaccines going to be the next blockbuster vaccine to be developed?The below graph shows that the rate of RSV-associated hospitalizations has increased significantly after the COVID pandemic (2020–2021…Nov 20, 2022Nov 20, 2022
BioCompoundingInvesting Basics 101: 3 Essential Guidelines for Asset AllocationAsset allocation is one of the first decisions to need to make when building a portfolio that suits your needs and goals; when you need the…Nov 13, 2022Nov 13, 2022
BioCompounding3 No-Brainer High Growth Pharma Stocks to Consider1. Novo Nordisk (NVO)Nov 6, 2022Nov 6, 2022
BioCompoundingAlnylam Pharmaceuticals (NASDAQ: ALNY) Stock Deep DiveFounded in 2002, Alnylam has led the commercialization of RNAi. However, the company has faced multiple battles on its way here.Oct 30, 2022Oct 30, 2022
